234
|
Silencing LncRNA SNHG1
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
233
|
Silencing CASC11
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
232
|
silencing LncRNA RMRP
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
231
|
Silencing LncRNA SNHG7
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
229
|
Metastasis and Angiogenesis
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
230
|
Drug Resistance
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
228
|
Migration
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
227
|
Migration/Metastasis and Invasion in MYCN amplified cells
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
225
|
Cisplatin Resistant cells
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
226
|
BCO1 overexpression
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
224
|
Migration/Metastasis and Invasion in Non-Amplified MYCN
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
223
|
Migration & Invasion
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
221
|
Invasion
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
222
|
p53-wild type
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
220
|
Low MYCN level
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
219
|
1p36 Deletion
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
218
|
Non-Amplified MYCN (Non-MNA)
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
217
|
Poor Survival
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
216
|
MYCN amplified (MNA) and Metastasis
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
215
|
Well differentiated/ Favorable Histology Low‐Risk group
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |